Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 412-050-4 | CAS number: 125109-85-5 FLORHYDRAL
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
NOAEL oral rat = 300mg/kg bw/d in an OECD 407, GLP study from 1991.
Key value for chemical safety assessment
- Toxic effect type:
- dose-dependent
Repeated dose toxicity: via oral route - systemic effects
Link to relevant study records
- Endpoint:
- short-term repeated dose toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1991
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 407 (Repeated Dose 28-Day Oral Toxicity Study in Rodents)
- GLP compliance:
- yes
- Limit test:
- no
- Specific details on test material used for the study:
- Batch number 183831
Purity 97.3% - Species:
- rat
- Strain:
- other: Fü-Albino
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Standard lab conditions
- Route of administration:
- oral: gavage
- Vehicle:
- other: Standard Suspending Vehicle (5g sodium-carboxymethylcellulose, 4mL Tween 80, 5mL Benzyl aclohol, 9g NaCl, distilled water up to 1000mL)
- Details on oral exposure:
- Daily volume of 10ml/kg/d of a dilution of the tiest item in SSV was given to rats by gavage.
- Analytical verification of doses or concentrations:
- yes
- Duration of treatment / exposure:
- 28 d
- Frequency of treatment:
- daily
- Dose / conc.:
- 60 mg/kg bw/day (actual dose received)
- Dose / conc.:
- 300 mg/kg bw/day (actual dose received)
- Dose / conc.:
- 1 500 mg/kg bw/day (actual dose received)
- No. of animals per sex per dose:
- 6
- Control animals:
- yes, concurrent vehicle
- Details on study design:
- According to guideline.
- Positive control:
- none
- Observations and examinations performed and frequency:
- bodyweight (on D0 and weekly), symptoms (8hrs following administration daily), mortalities (continuously), opthalmoscopy (prior to termination), lab investigation and blood analysis, full necropsy and histological investigations.
- Sacrifice and pathology:
- At the termination of the study the animals were euthanized by the use of CO2 and rapidly exsanguinated by incision of the neck. Immediately afterwards, all animlas were subjected to a full necropsy and macroscopy.
- Statistics:
- Data were processed to give group mean values (X) and standard desviations, where applicable. Appropriate statistical analyses (eg Kruskal-Wallis Anova and Mann-Whitney U-tests, Dunn-test, Jonckheere-test) were used to assess the significance of the results, where inspection of the data indicated the possibility of a response to treatment.
- Clinical signs:
- effects observed, treatment-related
- Description (incidence and severity):
- At 1500 mg/kg/d, males showed slight sedation on D2 and D3 10-15 minutes after test item administration, that lasted for up to 1 hour. Females showed slight sedation on D1 starting 45 minutes after test item administration and lasting up to 90 minutes. Sedation effects increased in females following further administration leading in some cases to a need for euthanasia.
At 300mg/kg/d, slight sedation only noticed in one female and one male on D2 and D3.
At 60mg/kg/d, no symptomes detected. - Mortality:
- mortality observed, treatment-related
- Description (incidence):
- At 1500 mg/kg/d, 2 females were euthanized for humane reasons in a deeply comatose and moribund state approximately 6 hours after receiving the 3rd dose.
3 accidental casualties (1 M + 1F in the low-dose group on day 5 and 11, and 1F of mid-dose on day 10) due to aspiration of test article into the lungs followed by alveolar haemorrage and oedema. - Body weight and weight changes:
- effects observed, treatment-related
- Description (incidence and severity):
- At 1500 mg/kg/d, body weight gain statisitically inferior to control in males.
No statistical difference in males of mid- and low-dose and for females of all doses. - Food consumption and compound intake (if feeding study):
- not examined
- Food efficiency:
- not examined
- Water consumption and compound intake (if drinking water study):
- not examined
- Ophthalmological findings:
- no effects observed
- Haematological findings:
- no effects observed
- Description (incidence and severity):
- All parameters remained within physiological range for the rat strain used, no biological relevance was detected.
At 1500 mg/kg/d, statistically significant increase in leukocyte count and marginal but statistically significant reduction in fibrinogen was found in males. Relation with treatment is unclear. - Clinical biochemistry findings:
- effects observed, non-treatment-related
- Description (incidence and severity):
- Measured parameters generally remainde within physiological range known to be valide for Fü-albino rats of similar age and no biologically meaningful alterations were shown.
At 1500 mg/kg/d, statistically significant decrease in total protein was noticed in males but remained within normal range. - Urinalysis findings:
- no effects observed
- Behaviour (functional findings):
- not examined
- Immunological findings:
- not examined
- Organ weight findings including organ / body weight ratios:
- effects observed, treatment-related
- Description (incidence and severity):
- At 1500 mg/kg/d, increase in relative kidney weight of the male and female high-dose groups.
At 1500 mg/kg/d and 300mg/kg/d, statistically significant increase of the absolute and relative liver weights in males and females. - Gross pathological findings:
- no effects observed
- Neuropathological findings:
- not examined
- Histopathological findings: non-neoplastic:
- no effects observed
- Histopathological findings: neoplastic:
- no effects observed
- Other effects:
- not examined
- Dose descriptor:
- NOAEL
- Effect level:
- 300 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- clinical signs
- Critical effects observed:
- not specified
- Conclusions:
- From the results present in this study, the NOAEL for systemic toxicity of the test item is 300mg/kg/d.
- Executive summary:
Groups of 6 animals per sex per dose were used. Test material in Standard Suspending Vehicle (SSV) was administered daily by oral gavage to outbred stock.Ibm:RORO(SPF) animals of both sexes for a period of 28 days. Dose volume was 10 ml/kg bodyweight per day. A control group with 6 males and 6 females was also included. The control group received the vehicle SSV. Animals were 6-7 weeks old at the start of the study. Male animals weighed 205 +/- 4.51 grams and females weighed 192 +/- 4.65 grams at the beginning of the study. Animals were housed in in stainless steel wire mesh cages, 2 rats of the same sex and group per cage. Food and water were provided ad libitum. The animal room temperature was 22 +/- 2 C with relative humidity between 55% +/- 10%. A 12 hour fluorescent light/12 hour dark cycle was used. Observations for mortality were continuous. Animals were inspected daily for up to 8 hours following the test material administration for behaviour, appearance, and signs of toxicity. Individual body weights were recorded on day 0, at weekly intervals thereafter and prior to feed withdrawal at termination of the study. Opthalmoscopy was performed prior to termination of the study. At the end of the dosing period, blood samples were withdrawn for hematology and clinical chemistry analyses. In addition, urine was collected for urinalysis. All animals were sacrificed, necropsied and examined post mortem. Organ weights were determined and a series of tissues were removed and prepared for histological evaluation
SSV contained: 5 grams sodium-carboxymethylcellulose, 4 ml Tween 80, 5 ml benzyl alcohol p.a. Merck, 9 grams NaCl p. a. Merck and distilled water ad 1000 ml.
OECD guidelines for testing of chemicals, ed. May 12, 1981; repeated dose oral toxicity - rodent: 28 day study; Part No. 407: pages 1-8.
NOAEL was set at 300mg/kg/d
Reference
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- NOAEL
- 300 mg/kg bw/day
- Study duration:
- subacute
- Experimental exposure time per week (hours/week):
- 168
- Species:
- rat
- Quality of whole database:
- Klimisch 1, GLP and guideline study
Repeated dose toxicity: inhalation - systemic effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Repeated dose toxicity: inhalation - local effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Repeated dose toxicity: dermal - systemic effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Repeated dose toxicity: dermal - local effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Justification for classification or non-classification
According to the test results available, the substance does not need to be classified for repeated dose toxicity under CLP.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.